ViaDerma, Inc.
VDRM
Rank in Stocks
#33953
ViaDerma, Inc., a specialty pharmaceutical enterprise based in the United... ViaDerma, Inc., a specialty pharmaceutical enterprise based in the United States, focuses on both the development and commercialization of pharmaceutical products. It also licenses its proprietary technology to other companies within the pharmaceutical sector, addressing various therapeutic areas. The company's primary offering is Vitastem, a topical antibiotic containing tetracycline, effective for treating a broad spectrum of ailments such as cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. Beyond its established products, ViaDerma is dedicated to expanding its pipeline, with ongoing development in fields including advanced topical antibiotics, antifungal treatments for toenails, diabetic amputation recovery, general acne, psoriasis, eczema, burn care, anti-aging and wrinkle-reducing formulations, medical cannabis applications, male pattern baldness, skin cancer, erectile dysfunction, and pain management. Established in 2007, the company operated as Dรฉcor Products International, Inc. until its renaming to ViaDerma, Inc. in May 2014. Its corporate operations are directed from Marina Del Rey, California.
Share Price
$0.0001
Last synced: 2026-11-09
Market Cap
$123.37K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade ViaDerma, Inc. (VDRM)
Category
Healthcare
EPS for ViaDerma, Inc. (VDRM)
EPS as of September 2024 TTM: $0.00
According to ViaDerma, Inc.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2023 the company had an EPS of 0.00, equal to its 2022 EPS of 0.00.
EPS history for ViaDerma, Inc. from 2007 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -100.00% |
| 2023 | 0.00 | -100.00% |
| 2022 | 0.00 | -160.00% |
| 2021 | 0.00 | 66.67% |
| 2020 | 0.00 | -25.00% |
| 2019 | 0.00 | -83.67% |
| 2018 | 0.00 | 22.50% |
| 2017 | 0.00 | 400.00% |
| 2016 | 0.00 | -366.67% |
| 2015 | 0.00 | -100.00% |
| 2011 | $19.50 | -40.91% |
| 2010 | $33.00 | 8.20% |
| 2009 | $30.50 | -21,885.71% |
| 2008 | $-0.14 | -98.87% |
| 2007 | $-12.44 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | -3,250,800.00% |
DE
|
|
| $6.08 | -3,038,900.00% |
DE
|
|
| $1.55 | -775,400.00% |
JP
|
|
| $3.66 | -1,830,100.00% |
CH
|
|
| $0.45 | -225,100.00% |
IL
|
Questions about ViaDerma, Inc.'s earnings per share (EPS)
What is ViaDerma, Inc.'s earnings per share (EPS)?
ViaDerma, Inc.'s earnings per share (EPS) over the last twelve months is $0.00, as of Sep 2024.
What was ViaDerma, Inc.'s earnings per share (EPS) in 2023?
In 2023, ViaDerma, Inc.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2022.
How has ViaDerma, Inc.'s earnings per share (EPS) changed since 2018?
From 2018 to 2023, ViaDerma, Inc.'s earnings per share (EPS) was highest in 2023 (0.00) and lowest in 2023 (0.00).
How does ViaDerma, Inc.'s earnings per share (EPS) compare with similar companies?
ViaDerma, Inc.'s earnings per share (EPS) ($0.00) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.